Atopica provides long-term, well-tolerated relief from atopic dermatitis1-4 with a broad mode of action that targets the source of inflammation.


  • Proven to relieve itch and reduce skin lesions in dogs5,6


  • Long-term relief with lasting results6,7


  • Flexible, tapered dosing lowers costs for dog owners over time


Box packaging of Atopica® for dogs


 Proven relief

Atopica clinical trials included dogs treated for six weeks5 and for 16 weeks at full or reduced dose as determined by clinical need.6

Over the entire 16-week study:6

  • Pruritus score improved
  • Alopecia score improved
  • Skin lesion score improved


Well-tolerated treatment

  • Atopica is approved for long-term use.
  • Side effects such as vomiting and diarrhea are generally mild and transient, and don’t always require stopping treatment.


Flexible treatment for cost-effective, long-lasting control

Indication
Atopica® is indicated for the control of atopic dermatitis in dogs weighing at least 4 pounds and at least 6 months of age.

Important Safety Information

Do not use Atopica® in dogs with a history of neoplasia, with a hypersensitivity to cyclosporine, or in reproducing dogs. Atopica is a systemic immunosuppressant that may increase susceptibility to infection and the development of neoplasia. For use only in dogs. Capsules should not be broken or opened. Wear gloves during administration and wash hands after administration. Gastrointestinal problems and gingival hyperplasia may occur at the initial dose. For full prescribing information, see package label.

About Elanco

Learn why we're a leading provider of innovative solutions that protect and enhance animal health.

Connect with Elanco

Atopica, Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. PM-US-21-3181

© 2024 Elanco or its affiliates.